Autologous hematopoietic stem cell transplantation

Advertisement
DocWire News EditorsASH Annual Meeting and Exposition 2021 | July 5, 2023
According to findings presented at the 2021 ASH Annual Meeting, the combination of daratumumab, carfilzomib, ...
Read More
DocWire News EditorsASH Annual Meeting and Exposition 2021 | July 5, 2023
The combination of daratumumab, carfilzomib, lenalidomide, and dexamethasone (Dara-KRd), autologous hematopoietic cell ...
Rebecca AraujoOncology | July 5, 2023
A study of patients aged ≥60 years with lymphoma found that a high-dose chemotherapy regimen followed by autologous ...
Rebecca AraujoOncology | July 5, 2023
New guidelines from the International Osteoporosis Foundation (IOF) address management of osteoporosis, fracture risk, ...
Rebecca AraujoOncology | March 31, 2023
Researchers from the University of British Columbia and Vancouver General Hospital evaluated incidence and risk factors ...
Kaitlyn D’OnofrioOncology | July 5, 2023
Patients with mantle cell lymphoma who are unmarried, have a lower educational level, or with multiple comorbidities are ...
Kaitlyn D’OnofrioOncology | July 5, 2023
A study examined longitudinal trends in the frailty state of blood or bone marrow transplantation (BMT) survivors. The ...
Rebecca AraujoOncology | July 5, 2023
Parameswaran Hari, MD, Chief of Hematology/Oncology at the Medical College of Wisconsin, spoke with DocWire News about ...
Kaitlyn D’OnofrioOncology | July 5, 2023
Patients with multiple myeloma (MM) who underwent double autologous  hematopoietic cell transplantation (AHCT) did not ...
Rebecca AraujoOncology | July 5, 2023
DocWire News spoke with Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical ...
Rebecca AraujoASH Annual Meeting 2020 | July 5, 2023
Findings presented at the 2020 American Society of Hematology Annual Meeting & Exposition suggest that ejection ...
DocWire News EditorsASH Annual Meeting 2020 | August 28, 2023
A study has found that the addition of rituximab to ixazomib, when used as maintenance therapy following autologous ...
Rebecca AraujoOncology | July 5, 2023
Maintenance therapy following autologous hematopoietic cell transplantation (AHCT) did not significantly impact survival ...
Rebecca AraujoOncology | July 5, 2023
In light-chain (AL) amyloidosis, a rare plasma cell disease marked by excess deposit of protein in the organs, the goal ...
Kerri FitzgeraldOncology | July 5, 2023
A study presented at the 2020 Society of Hematologic Oncology Annual Meeting found that the addition of ixazomib to ...
Kerri FitzgeraldOncology | July 5, 2023
Researchers compared the efficacy of lenalidomide and dexamethasone paired with carfilzomib or bortezomib for the ...
Kerri FitzgeraldOncology | July 5, 2023
A study published in Blood Advances observed significant differences in the use of novel therapy and autologous ...
Kerri FitzgeraldOncology | July 5, 2023
The U.S. Food and Drug Administration (FDA) approved the combination of Darzalex® (daratumumab) plus Velcade® ...
Kerri FitzgeraldEuropean Society of Hematology 2019 | July 5, 2023
Research presented at the European Hematology Association 24th Congress found that the addition of daratumumab to ...
Kerri FitzgeraldASH Annual Meeting 2018 | July 7, 2023
Jonathan U. Peled, MD, of Memorial Sloan Kettering Cancer Center discusses his study which looked at whether pre-HCT ...
Advertisement
Advertisement
Advertisement
Latest News

March 14, 2025